Lipella Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Lipella Pharmaceuticals Inc. (LIPO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.33% for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-11-14
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 4.33%.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 2.31%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month |
|---|---|---|---|
| 2024-09-30 | 4.33% 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | 4.33% 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | 4.33% 10-Q · filed 2025-05-14 | ||
| 2023-09-30 | 3.99% 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | 3.99% 10-Q · filed 2024-08-13 | ||
| 2022-09-30 | 2.31% 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | 2.31% 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | 2.31% 10-Q · filed 2023-05-12 |